Close
Novotech
Jabsco PureFlo 21 Single Use

News

Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep

Thermo Fisher Scientific Inc., the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's...

Dr. Reddy’s receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India

Dr. Reddy’s Laboratories Ltd announced that it has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the Sputnik V vaccine in India. The phase 3 study of Sputnik V will be...

COVID-19 vaccine: Bharat Biotech set to dispatch first consignment of Covaxin

Hyderabad, Bharat Biotech, which has received Emergency Use Authorisation approval from theDrug Controller General of Indiafor its COVID-19 vaccine Covaxin, is set to dispatch it from the Rajv Gandhi International Airport here on Tuesday evening, a senior official of...

Parexel Completes Separation of Parexel Informatics and Medical Imaging Business

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, announced it has completed the separation of its Parexel Informatics and Medical Imaging business. The strategic...

Lonza to Partner with Capricor Therapeutics for the Development of Duchenne Muscular Dystrophy Cell Therapy

Lonza and Capricor Therapeutics, a US-based clinical-stage biotechnology company, announced on Jan. 12, 2020 that they are entering into an agreement for the development of CAP-1002, Capricor's clinical cell therapy that uses allogeneic cardiosphere-derived cells technology for the treatment...

Bharat Biotech signs agreement with Precisa Medicamentos to supply Covaxin to Brazil

Bharat  Biotech announced  that  it  has  signed  an agreement  with Precisa Medicamentos for the supplies of COVAXIN™ to Brazil. A team from Precisa Medicamentos has visited the Bharat Biotech facility last week to discuss potential export possibilities of COVAXIN™, India’s...

US FDA grants emergency use authorization to Quanterixs Simoa SARS-CoV-2 N protein antigen test

Quanterix Corporation, a company digitizing biomarker analysis to advance the science of precision health, announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its Simoa SARS-CoV-2 N Protein Antigen Test that can...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »